About Clinical Cancer Research

Scope

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, molecular alterations and biomarkers that predict response or resistance to treatment. The Journal will consider laboratory and animal studies of new drugs and molecularly-targeted agents that are approved for clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.

Specific areas of interest include clinical research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; antibody-based therapy; cellular and gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; innovative imaging and other novel methods with applicability to clinical investigation; clinical genetics; detection of minimal residual disease; and clinical artificial intelligence.

Manuscript Submission

Clinical Cancer Research welcomes submissions of primary research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.

The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Instructions for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.

Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication.

Submit your article to Clinical Cancer Research

Journal Metrics

For detailed metrics about Clinical Cancer Research and the other AACR journals see the AACR Journals Metrics.

Editors and Editorial Board

Editorial oversight of Clinical Cancer Research and decisions on manuscripts submitted to the journal are the responsibility of the Editor-in-Chief and Executive Editor.

Copyright, Permissions and Access

Material published in Clinical Cancer Research is covered and protected by copyright. An author can either formally transfer copyright to the AACR, and be granted considerable reuse rights, or can publish an article as open access under a Creative Commons license. In addition, the AACR assists authors in satisfying major funder Open Access archiving mandates by depositing the accepted author version of their article in a designated public repository. For additional details about all these topics, see Copyright, Permissions and Access.

Publication Fees

To defray publication costs and to support other AACR programs, publication in Clinical Cancer Research involves the payment of a base publication fee and an additional fee for each display item. If no financial support exists, authors may apply for a waiver of the fixed publication fee at the time of submission. See Publication Fees for further details.

Journal Information

Clinical Cancer Research (CCR) (Print ISSN: 1078-0432; Online ISSN: 1557-3265) is published twice a month, one volume/year, by the American Association for Cancer Research, Inc. (AACR).

Clinical Cancer Research is abstracted and/or indexed in MEDLINE, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.

Back Issues and Single Copy Sales

Subject to availability, single or back issues of Clinical Cancer Research may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact:

AACR Publications Sales & Marketing Department
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Phone: (215) 440-9300; or Toll Free: (855) 744-4667
E-mail: [email protected]

Contact